Literature DB >> 6116646

Investigation of cerebrospinal fluid neuropeptides in idiopathic senile dementia.

J J Oram, J Edwardson, P H Millard.   

Abstract

Thyrotrophin-releasing hormone and gonadotrophin-releasing hormone were measured in lumbar CSF from patients with idiopathic senile dementia, cerebral tumours and spinal disc lesions. Somatostatin was also measured in lumbar CSF from patients with dementia and patients with other neurological disorders, but the numbers involved were much smaller. The levels of these neuropeptides were significantly reduced in the patients with senile dementia. These results suggest a possible involvement of hpothalamic neuropeptides in idiopathic senile dementia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116646     DOI: 10.1159/000212476

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  9 in total

1.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  CSF and plasma vasopressin concentrations in dementia.

Authors:  P S Sørensen; M Hammer; S Vorstrup; F Gjerris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

3.  Last scene of all.

Authors:  P H Millard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

4.  Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Authors:  A M Mellow; T Sunderland; R M Cohen; B A Lawlor; J L Hill; P A Newhouse; M R Cohen; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

6.  Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.

Authors:  H Cramer; D Schaudt; K Rissler; D Strubel; J M Warter; F Kuntzmann
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

7.  Predator stress induces behavioral inhibition and amygdala somatostatin receptor 2 gene expression.

Authors:  S A Nanda; C Qi; P H Roseboom; N H Kalin
Journal:  Genes Brain Behav       Date:  2008-03-21       Impact factor: 3.449

Review 8.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

9.  Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.

Authors:  S Jost; C Reuner; J Geiger; M Mohadjer; E Milios; H Cramer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.